Repligen Corporation (RGEN) has a market capitalization of $7.38B and trades at $131.03. The 52-week range is 102.97-175.77.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 150.6, Earnings Per Share (EPS) of $0.87, annual revenue of $738.26M.
The stock has a beta of 1.19, operates in the Healthcare sector.
